DeepCurrents Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

DeepCurrents Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5M	Buy	71,636 +1,150	+2%	+$201K	0.43%	75
2025 Q4	$12M	Buy	70,486 +136	+0.2%	+$20.9K	0.39%	82
2025 Q3	$9.27M	Buy	70,350 +3,747	+6%	+$449K	0.24%	93
2025 Q2	$7.07M	Buy	66,603 +14,550	+28%	+$1.58M	0.24%	89
2025 Q1	$6.46M	Buy	+52,053	New	+$6.79M	0.2%	109
2022 Q3	–	Sell	-43,249	Closed	-$6.75M	–	240
2022 Q2	$6.75M	Sell	43,249 -125,954	-74%	-$19.4M	0.27%	84
2022 Q1	$26.3M	Buy	169,203 +28,021	+20%	+$4.07M	0.82%	37
2021 Q4	$18M	Buy	141,182 +42,446	+43%	+$5.58M	0.56%	52
2021 Q3	$12.9M	Buy	+98,736	New	+$14.9M	0.38%	65
2019 Q2	–	Sell	-28,069	Closed	-$4.01M	–	95
2019 Q1	$4.01M	Buy	28,069 +22,888	+442%	+$2.99M	0.35%	54
2018 Q4	$643K	Buy	+5,181	New	+$769K	0.08%	85

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

DeepCurrents Investment Group's JAZZ Position: Q1 2026 in Review

DeepCurrents Investment Group increased its Jazz Pharmaceuticals (JAZZ) stake by 1.6% in Q1 2026, buying an estimated $201K and bringing the position to 71,636 shares worth $13.5M. The position accounts for 0.43% of the portfolio, ranked #75.

DeepCurrents Investment Group first reported a position in JAZZ in Q4 2018 and has held it in 11 quarters since. The position peaked at $26.3M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

DeepCurrents Investment Group held 71,636 shares of Jazz Pharmaceuticals worth $13.5M as of Q1 2026.
DeepCurrents Investment Group bought 1,150 Jazz Pharmaceuticals shares in Q1 2026, an estimated $201K.
Jazz Pharmaceuticals made up 0.43% of DeepCurrents Investment Group's portfolio in Q1 2026, its #75 holding.
DeepCurrents Investment Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 11 quarters since.
DeepCurrents Investment Group's Jazz Pharmaceuticals position peaked at $26.3M in Q1 2022.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on DeepCurrents Investment Group's 13F filing for Q1 2026, filed 15 May 2026.